Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1M | $1.3M | $909,598 | $539,686 | $1.3M | $828,450 | $1.6M | $1.5M | $1.5M | $1.2M | $2.0M | $1.6M | — | — | — | — | — |
| Research & development | $30,358 | $15,191 | $33,152 | $609,127 | $580,000 | $628,304 | $1.0M | $863,401 | $799,702 | $1.4M | $1.6M | $1.6M | $2.2M | $1.7M | $1.4M | $1.4M | $1.5M |
| Operating expenses | $3.3M | $2.8M | $2.9M | $3.2M | $3.1M | $3.4M | $4.7M | $3.9M | $3.9M | $5.5M | $6.3M | $6.0M | $8.2M | $5.8M | $5.0M | $4.7M | $4.7M |
| Operating income | −$2.1M | −$1.4M | −$2.0M | −$2.6M | −$1.8M | −$2.6M | −$3.1M | −$2.4M | −$2.4M | −$4.3M | −$4.3M | −$4.4M | −$6.1M | −$3.8M | −$4.2M | −$3.9M | −$4.0M |
| EBITDAderived | −$2.1M | −$1.4M | −$2.0M | −$2.6M | −$1.8M | −$2.5M | −$3.0M | −$2.2M | −$2.2M | −$4.1M | −$4.2M | −$4.4M | −$6.0M | −$3.8M | −$4.1M | −$3.8M | −$4.0M |
| Net income | −$2.0M | −$1.3M | −$1.9M | −$2.7M | −$1.8M | −$2.3M | −$3.8M | −$2.7M | −$2.4M | −$4.2M | −$4.3M | −$4.4M | −$6.0M | −$3.2M | −$4.1M | −$3.9M | −$4.0M |
| Basic EPSper diluted share | -$0.06 | -$0.04 | -$0.06 | -$0.08 | -$0.06 | -$0.07 | -$0.13 | -$0.10 | -$0.10 | -$0.18 | -$0.18 | -$0.19 | -$0.26 | -$0.16 | -$0.22 | -$0.22 | -$0.25 |
| Diluted EPSper diluted share | -$0.06 | -$0.04 | -$0.06 | -$0.08 | -$0.06 | -$0.07 | -$0.13 | -$0.10 | -$0.10 | -$0.18 | -$0.18 | -$0.19 | -$0.26 | -$0.16 | -$0.22 | -$0.22 | -$0.25 |